QA102
/ MingMed Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
January 07, 2025
AMEND: QA102 Phase II Study in Subjects With Dry AMD
(clinicaltrials.gov)
- P2 | N=150 | Completed | Sponsor: Smilebiotek Zhuhai Limited | Active, not recruiting ➔ Completed
Trial completion • Age-related Macular Degeneration • Dry Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders
January 26, 2024
AMEND: QA102 Phase II Study in Subjects With Dry AMD
(clinicaltrials.gov)
- P2 | N=145 | Active, not recruiting | Sponsor: Smilebiotek Zhuhai Limited | Trial completion date: Oct 2025 ➔ Jan 2025 | Trial primary completion date: Oct 2025 ➔ Jan 2025
Trial completion date • Trial primary completion date • Age-related Macular Degeneration • Dry Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders
August 04, 2023
AMEND: QA102 Phase II Study in Subjects With Dry AMD
(clinicaltrials.gov)
- P2 | N=145 | Active, not recruiting | Sponsor: Smilebiotek Zhuhai Limited | Recruiting ➔ Active, not recruiting | N=240 ➔ 145
Enrollment change • Enrollment closed • Age-related Macular Degeneration • Dry Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders
October 12, 2022
AMEND: QA102 Phase II Study in Subjects With Dry AMD
(clinicaltrials.gov)
- P2 | N=240 | Recruiting | Sponsor: Smilebiotek Zhuhai Limited | Not yet recruiting ➔ Recruiting
Enrollment open • Age-related Macular Degeneration • Dry Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders
September 13, 2022
AMEND: QA102 Phase II Study in Subjects With Dry AMD
(clinicaltrials.gov)
- P2 | N=240 | Not yet recruiting | Sponsor: Smilebiotek Zhuhai Limited
New P2 trial • Age-related Macular Degeneration • Dry Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders
1 to 5
Of
5
Go to page
1